Aimed Bio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	94,557	23,520	171.21	111.09
Revenue Growth (YoY)	302.02%	13637.41%	54.12%	-
Gross Profit	94,557	23,520	171.21	111.09
Selling, General & Admin	51,638	22,872	5,529	4,922
Amortization of Goodwill & Intangibles	294.32	120.25	64.32	49.76
Operating Expenses	53,020	24,336	6,588	5,703
Operating Income	41,537	-815.51	-6,416	-5,592
Interest Expense	-57.03	-93.11	-119.08	-123.26
Interest & Investment Income	1,840	1,117	207.22	162.72
Currency Exchange Gain (Loss)	-1,473	179.88	7.27	60.6
Other Non Operating Income (Expenses)	-50,579	-7,022	-1,617	11.45
EBT Excluding Unusual Items	-8,732	-6,634	-7,938	-5,480
Gain (Loss) on Sale of Investments	-635.25	193.5	-1,084	-716.25
Gain (Loss) on Sale of Assets	-32.43	1.32	-7.24	-12.95
Pretax Income	-9,399	-6,439	-9,030	-6,210
Income Tax Expense	-9,183	-	-	-
Earnings From Continuing Operations	-216.93	-6,439	-9,030	-6,210
Minority Interest in Earnings	4.48	9.28	6.95	41.03
Net Income	-212.45	-6,430	-9,023	-6,168
Net Income to Common	-212.45	-6,430	-9,023	-6,168
Shares Outstanding (Basic)	-	69	34	33
Shares Outstanding (Diluted)	-	69	34	33
Shares Change (YoY)	-	102.43%	2.16%	-
EPS (Basic)	108.00	-93.00	-264.18	-184.51
EPS (Diluted)	101.00	-93.00	-264.18	-184.51
Free Cash Flow	31,276	-14,887	-3,440	-4,360
Free Cash Flow Per Share	-	-215.33	-100.72	-130.42
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Margin	43.93%	-3.47%	-3747.54%	-5033.36%
Profit Margin	-0.22%	-27.34%	-5269.87%	-5552.44%
Free Cash Flow Margin	33.08%	-63.29%	-2009.11%	-3924.65%
EBITDA	42,919	648.3	-5,358	-4,811
EBITDA Margin	45.39%	2.76%	-	-
D&A For EBITDA	1,382	1,464	1,058	780.45
EBIT	41,537	-815.51	-6,416	-5,592
EBIT Margin	43.93%	-3.47%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.